MICROBA LIFE SCIENCES LIMITED — Investor Relations & Filings

Microba Life Sciences Limited is a precision microbiome company focused on the analysis of the human gut microbiome to improve health outcomes. The company utilizes advanced shotgun metagenomic sequencing technology to provide high-resolution insights into microbial composition and function. Its core operations include the delivery of comprehensive microbiome testing services to consumers and healthcare practitioners, as well as the provision of specialized research and data analysis services to pharmaceutical and biotechnology partners. Microba leverages its proprietary Microba Community Analysis Platform (MCAP) and an extensive human gut microbiome database to identify novel therapeutic leads and support clinical research. The company's drug discovery efforts target inflammatory bowel disease, cancer immunotherapy, and other chronic conditions by identifying specific bacterial strains with therapeutic potential.